17Indexed trials
mesh condition
Marijuana Abuse
Intelligence
Marijuana Abuse intelligence: 17 indexed trials, 3 recruiting studies, 15 sponsors across 7 countries.
3Recruiting
15Sponsors
7Countries
Leading sponsors
University of Colorado, Denver20 recruiting
Medical University of South Carolina20 recruiting
Colorado State University10 recruiting
Fenix Innovation Group11 recruiting
Laboratorio Elea Phoenix S.A.11 recruiting
Massachusetts General Hospital10 recruiting
Michael, Levy M.D.,Ph.D.10 recruiting
New York State Psychiatric Institute10 recruiting
Radboud University Medical Center10 recruiting
St. Joseph's Healthcare Hamilton10 recruiting
The Epilepsy Research Program of the Ontario Brain Institute10 recruiting
University of California, San Diego10 recruiting
Geographic activity
United States8trials
Canada2trials
Argentina1trials
Israel1trials
Netherlands1trials
France1trials
Australia1trials
Leading interventions
5:1 CBD/THC1trials
Atomoxetine1trials
Cannabidiol1trials
Cannabidiol 100 mg/ml1trials
Cannabidiol 400 mg/ml1trials
Cannabis oil1trials
Contingency management1trials
Delta-THC1trials
Guanfacine1trials
Matching Placebo1trials
Medical Cannabis1trials
25:1 CBD/THC1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.